Cargando…
Oprozomib in patients with newly diagnosed multiple myeloma
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697695/ https://www.ncbi.nlm.nih.gov/pubmed/31420532 http://dx.doi.org/10.1038/s41408-019-0232-6 |
| _version_ | 1783444414840963072 |
|---|---|
| author | Hari, Parameswaran Matous, Jeffrey V. Voorhees, Peter M. Shain, Kenneth H. Obreja, Mihaela Frye, John Fujii, Hisaki Jakubowiak, Andrzej J. Rossi, Davide Sonneveld, Pieter |
| author_facet | Hari, Parameswaran Matous, Jeffrey V. Voorhees, Peter M. Shain, Kenneth H. Obreja, Mihaela Frye, John Fujii, Hisaki Jakubowiak, Andrzej J. Rossi, Davide Sonneveld, Pieter |
| author_sort | Hari, Parameswaran |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6697695 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66976952019-08-26 Oprozomib in patients with newly diagnosed multiple myeloma Hari, Parameswaran Matous, Jeffrey V. Voorhees, Peter M. Shain, Kenneth H. Obreja, Mihaela Frye, John Fujii, Hisaki Jakubowiak, Andrzej J. Rossi, Davide Sonneveld, Pieter Blood Cancer J Correspondence Nature Publishing Group UK 2019-08-16 /pmc/articles/PMC6697695/ /pubmed/31420532 http://dx.doi.org/10.1038/s41408-019-0232-6 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Hari, Parameswaran Matous, Jeffrey V. Voorhees, Peter M. Shain, Kenneth H. Obreja, Mihaela Frye, John Fujii, Hisaki Jakubowiak, Andrzej J. Rossi, Davide Sonneveld, Pieter Oprozomib in patients with newly diagnosed multiple myeloma |
| title | Oprozomib in patients with newly diagnosed multiple myeloma |
| title_full | Oprozomib in patients with newly diagnosed multiple myeloma |
| title_fullStr | Oprozomib in patients with newly diagnosed multiple myeloma |
| title_full_unstemmed | Oprozomib in patients with newly diagnosed multiple myeloma |
| title_short | Oprozomib in patients with newly diagnosed multiple myeloma |
| title_sort | oprozomib in patients with newly diagnosed multiple myeloma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697695/ https://www.ncbi.nlm.nih.gov/pubmed/31420532 http://dx.doi.org/10.1038/s41408-019-0232-6 |
| work_keys_str_mv | AT hariparameswaran oprozomibinpatientswithnewlydiagnosedmultiplemyeloma AT matousjeffreyv oprozomibinpatientswithnewlydiagnosedmultiplemyeloma AT voorheespeterm oprozomibinpatientswithnewlydiagnosedmultiplemyeloma AT shainkennethh oprozomibinpatientswithnewlydiagnosedmultiplemyeloma AT obrejamihaela oprozomibinpatientswithnewlydiagnosedmultiplemyeloma AT fryejohn oprozomibinpatientswithnewlydiagnosedmultiplemyeloma AT fujiihisaki oprozomibinpatientswithnewlydiagnosedmultiplemyeloma AT jakubowiakandrzejj oprozomibinpatientswithnewlydiagnosedmultiplemyeloma AT rossidavide oprozomibinpatientswithnewlydiagnosedmultiplemyeloma AT sonneveldpieter oprozomibinpatientswithnewlydiagnosedmultiplemyeloma |